- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: aggressive lymphoma
Total 10991 results
-
University of AarhusActive, not recruitingMalignant LymphomaNetherlands, Norway, Denmark, Finland, Sweden
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedAggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced NeutropeniaGermany, Italy, Spain
-
Jennifer WoyachKaryopharm Therapeutics IncActive, not recruitingRecurrent Adult Diffuse Large Cell Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Small Lymphocytic Lymphoma | Prolymphocytic Leukemia | Refractory Chronic Lymphocytic LeukemiaUnited States
-
Weill Medical College of Cornell UniversityFDA Office of Orphan Products Development; The Leukemia and Lymphoma Society; Karyopharm Therapeutics IncCompletedDiffuse Large B-Cell LymphomaUnited States
-
Alexion PharmaceuticalsPortola PharmaceuticalsCompletedFollicular Lymphoma (FL/Indolent NHL) | Aggressive NHL (a NHL) | Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL) | T-cell Lymphoma (PTCL and CTCL) | B-cell Non Hodgkin Lymphoma (NHL)United States
-
Johannes Gutenberg University MainzRoche Pharma AG; ServierCompleted
-
The First Affiliated Hospital with Nanjing Medical...Active, not recruitingLymphoma, Large B-Cell, Diffuse | Mantle Cell Lymphoma | Peripheral T Cell Lymphoma | Double-hit LymphomaChina
-
Fondazione Italiana Linfomi ONLUSCompletedAggressive Non-Hodgkin LymphomaItaly
-
CTI BioPharmaCompletedDiffuse Large B-cell Lymphoma | de Novo DLBCL | DLBCL Transformed From Indolent Lymphoma | Follicular Grade 3 LymphomaUnited States, Germany, Italy, United Kingdom, Hungary, France, Spain, Ukraine, Czechia, Austria, Belgium, Bulgaria, Denmark, Poland, Romania, Russian Federation, Slovakia
-
Gilead SciencesWithdrawnDiffuse Large B-cell Lymphoma | NHL | Non Hodgkin's Lymphoma | Aggressive NHLUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedRecurrent Adult Diffuse Large Cell Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Post-Transplant Lymphoproliferative Disorder | Recurrent Burkitt Lymphoma | Refractory Burkitt LymphomaUnited States
-
Universität des SaarlandesCompleted
-
SymBio PharmaceuticalsCompletedFollicular Lymphoma | Diffuse Large B-Cell Lymphoma | Non-Hodgkin's Lymphoma | Mantle Cell LymphomaJapan
-
Abramson Cancer Center of the University of PennsylvaniaTerminatedAcute Myelogenous LeukemiaUnited States
-
Novartis PharmaceuticalsCompletedLymphoma, Mantle- CellUnited States
-
German High-Grade Non-Hodgkin's Lymphoma Study...CompletedLymphomaGermany, Switzerland
-
University Health Network, TorontoHoffmann-La Roche; Ozmosis Research Inc.CompletedLymphoma, Non-Hodgkin'sCanada
-
AmgenCompletedB-Cell Non Hodgkin LymphomaUnited States, Spain, United Kingdom, Belgium, Italy, Australia, Canada, Puerto Rico
-
Northwestern UniversityBristol-Myers Squibb; National Cancer Institute (NCI); AbbVieUnknownUnresectable Solid Neoplasm | Recurrent Solid Neoplasm | Refractory Mantle Cell Lymphoma | Aggressive Non-Hodgkin Lymphoma | Advanced Solid Neoplasm | T-Cell Non-Hodgkin LymphomaUnited States
-
Washington University School of MedicineCelgeneCompletedLymphoma, Large B-Cell, Diffuse | Hodgkin Disease | Lymphoma, T-Cell, Cutaneous | Lymphoma, T-Cell, PeripheralUnited States
-
Sheba Medical CenterCity of Hope Medical Center; Amsterdam UMC, location VUmc; University of GöttingenCompletedNon-Hodgkin's LymphomaUnited States, Netherlands, Germany, Israel
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI); The Emmes Company, LLCCompletedLymphoma | Nonneoplastic ConditionUnited States
-
University Hospital, BrestCompletedDiagnostic Imaging | Relapsed Non Hodgkin Lymphoma | Relapsed Hodgkin's Disease, Adult | Malignant Lymphoma
-
M.D. Anderson Cancer CenterGenentech, Inc.Completed
-
University of California, San FranciscoWashington University School of Medicine; Eisai Inc.TerminatedPeripheral T-Cell LymphomaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaTerminatedLymphoblastic Leukemia | Burkitt's Lymphoma | CML | ALLUnited States
-
University Hospital, EssenCelgeneCompletedB-cell LymphomaGermany
-
CTI BioPharmaCompletedLymphoma, Non-HodgkinUnited States, United Kingdom, France, Italy, India, Germany, Hungary, Argentina, Uruguay, Russian Federation, Bulgaria, Costa Rica, Ecuador, Estonia, Mexico, Panama, Peru, Poland, Romania, Ukraine
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); The Wayne D. Kuni and Joan E. Kuni FoundationCompletedDiffuse Large B-Cell Lymphoma | Acute Myeloid Leukemia | Refractory Hodgkin Lymphoma | Previously Treated Myelodysplastic Syndrome | Recurrent Mantle Cell Lymphoma | Waldenstrom Macroglobulinemia | Acute Lymphoblastic Leukemia | Refractory Plasma Cell Myeloma | Recurrent Small Lymphocytic Lymphoma | Refractory... and other conditionsUnited States
-
Institut fuer anwendungsorientierte Forschung und...German High-Grade Non-Hodgkin's Lymphoma Study Group; University Hospital GoettingenCompleted
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute...CompletedRecurrent Hodgkin Lymphoma | Recurrent Adult Acute Myeloid Leukemia | Recurrent Mantle Cell Lymphoma | Waldenstrom Macroglobulinemia | Chronic Lymphocytic Leukemia | Non-Hodgkin Lymphoma | Recurrent Adult Acute Lymphoblastic Leukemia | Recurrent Childhood Acute Lymphoblastic Leukemia | Recurrent Childhood... and other conditionsUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Acute Myeloid Leukemia | Refractory Hodgkin Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Acute Lymphoblastic Leukemia | Myelodysplastic Syndrome | Chronic Phase Chronic Myelogenous Leukemia | Recurrent Small Lymphocytic Lymphoma | Chronic Myelogenous Leukemia | Refractory Chronic Lymphocytic Leukemia and other conditionsUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedHematopoietic and Lymphoid Cell Neoplasm | Recurrent Hodgkin Lymphoma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Childhood Acute Lymphoblastic Leukemia | Plasma Cell Myeloma | Recurrent Diffuse Large B-Cell Lymphoma | Prolymphocytic Leukemia | Refractory Chronic... and other conditionsUnited States, Denmark
-
Shandong Provincial HospitalUnknown
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedHematopoietic and Lymphoid Cell Neoplasm | Diffuse Large B-Cell Lymphoma | Acute Myeloid Leukemia | Refractory Hodgkin Lymphoma | Waldenstrom Macroglobulinemia | Acute Lymphoblastic Leukemia | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Myelodysplastic Syndrome | Prolymphocytic Leukemia | Refractory... and other conditionsUnited States, Germany, Denmark
-
Northwestern UniversityEli Lilly and Company; Millennium Pharmaceuticals, Inc.Terminated
-
Swiss Group for Clinical Cancer ResearchCompletedLymphoma | Leukemia | Multiple Myeloma and Plasma Cell Neoplasm | Mature T-cell and Nk-cell NeoplasmsSwitzerland
-
Swiss Group for Clinical Cancer ResearchCompleted
-
University Hospital, ToulouseCompleted
-
M.D. Anderson Cancer CenterAmgenTerminatedLymphomaUnited States
-
Meirav Kedmi MDJohnson & JohnsonUnknownDiffuse Large B Cell Lymphoma | Recurrent Disease | Refractory Cancer | Primary Mediastinal (Thymic) Large B-cell Lymphoma | Transformed Indolent LymphomaIsrael
-
PfizerUCB PharmaTerminatedLymphoma, Non-HodgkinCanada, United States, Spain, France, Singapore, Taiwan, Japan, Ireland, Belgium, United Kingdom, Germany, Slovakia, Thailand, Croatia, Czechia, Russian Federation, India, Sweden, Poland, Bulgaria, Hungary, Lithuania, Mexico, Puerto Rico and more
-
Yogen SaunthararajahCompletedT-cell Lymphoma | Indolent B-cell Lymphoma | Aggressive B-cell Lymphoma | Non-Hodgkin's LymphomasUnited States
-
University of GöttingenRoche Pharma AG; Mundipharma Research GmbH & Co KGCompleted
-
M.D. Anderson Cancer CenterCompletedNon-Hodgkin's LymphomaUnited States
-
Fujian Medical UniversityUnknownHigh-risk Aggressive Lymphoma After Auto-HSCTChina
-
University of ArizonaNational Cancer Institute (NCI)CompletedRecurrent Adult Diffuse Large Cell Lymphoma | Recurrent Mantle Cell Lymphoma | Anaplastic Large Cell LymphomaUnited States
-
Merck Sharp & Dohme LLCTerminatedLeukemia, Lymphocytic, Acute | Myelogenous Leukemia, Acute | Leukemia, Lymphoblastic, Acute, Philadelphia-Positive | Myelogenous Leukemia, Chronic, Aggressive Phase
-
PharmaMarCompletedLymphoma | LeukemiaItaly, France, Switzerland, Spain, Peru, Puerto Rico
-
Rennes University HospitalNational Cancer Institute, France; French Innovative Leukemia OrganisationCompleted